Medina Manuel Hidalgo - 17 Nov 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

SEC form
4
Accepted by SEC
18 Nov 2026, 17:37:01 UTC
Prior SEC filing
19 Oct 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Medina Manuel Hidalgo filed Form 4 for Guardant Health, Inc. (GH) on 18 Nov 2026.

Key facts

  • This page summarizes Medina Manuel Hidalgo's Form 4 filing for Guardant Health, Inc. (GH).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Nov 2026, 17:37.

Change

  • Previous filing in this sequence was filed on 19 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001865525 Primary reporting owner

Hidalgo Medina Manuel

Relationship
Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Options Exercise

Transaction value
Shares
+232
Change %
+4.4%
Price
$0.000000*
Shares after
5,484
Date
17 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-232
Change %
-4.8%
Price
$0.000000*
Shares after
4,641
Date
17 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
232
Exercise price
$0.000000
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.

Footnote F2

Not applicable for Restricted Stock Units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .